You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Litigation Details for Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. (D. Nev. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. (D. Nev. 2016)

Docket ⤷  Sign Up Date Filed 2016-10-31
Court District Court, D. Nevada Date Terminated 2020-03-30
Cause 35:271 Patent Infringement Assigned To Miranda Mai Du
Jury Demand None Referred To Nancy J. Koppe
Parties TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Patents 10,278,936; 7,022,713; 8,293,727; 8,293,728; 8,298,554; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,440,650; 8,518,929; 8,524,698; 8,546,372; 8,617,594
Attorneys Michael Kennedy
Firms Sterne, Kessler, Goldstein & Fox Pllc
Link to Docket External link to docket
Small Molecule Drugs cited in Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. (D. Nev. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-10-31 1 Complaint U.S. Patent No. 8,293,728 (“the ‘728 Patent”), U.S. Patent No. 8,318,715 (“the 7 ‘715 Patent”), U.…above. 2 33. United States Patent No. 8,293,728, entitled “METHODS OF TREATING 3 HYPERTRIGLYCERIDEMIA… Patent, the ‘335 Patent, the ‘399 Patent, 12 the ‘560 Patent, the ‘650 Patent, the ‘929 Patent, the…of the ‘728 Patent, the ‘715 Patent, the 11 ‘677 Patent, the ‘652 Patent, the ‘920 Patent, the ‘446 Patent…U.S. Patent No. 8,357,677 (“the ‘677 Patent”), U.S. Patent No. 8,367,652 (“the 8 ‘652 Patent”), U.S External link to document
2017-12-12 102 Response thirteen patents are all continuations of U.S. Patent No. 8,293,727 (“the ’727 patent”)—a 20 patent listed… patent, the ’715 patent, the ’677 patent, the ’652 patent, the ’920 patent, the ’446 patent, the …21 patent, the ’399 patent, the ’560 patent, the ’650 patent, the ’929 patent, the ’698 patent, and … ’594 patent”) is a continuation of U.S. Patent No. 8,298,554 23 (“the ’554 patent”)—a patent listed… 1 U.S. Patent Nos. 8,293,728 (“the ’728 patent”), 8,318,715 (“the ’715 patent”), 8,357,677 (“ External link to document
2018-08-10 135 Order but is discussed. It is U.S. Patent No. 8,293,727 (“the ‘727 28 patent”). …the ‘715 patent”); (3) U.S. Patent No. 8,357,677 (“the ‘677 9 patent”); (4) U.S. Patent No. 8,367,652…“the ‘652 patent”); (5) U.S. Patent No. 10 8,377,920 (“the ‘920 patent”); (6) U.S. Patent No. 8,399,446…“the ‘446 patent”); (7) U.S. 11 Patent No. 8,415,335 (“the ‘335 patent”); (8) U.S. Patent No. 8,426,399… ‘399 12 patent”); (9) U.S. Patent No. 8,431,560 (“the ‘560 patent”); (10) U.S. Patent No. 13 8, External link to document
2019-08-09 234 asserted patents, Dr. Toth agrees with my focus on the prosecution of U.S. Patent No. 8,293,727 (the “ʼ727…“ʼ727 patent”), which I understand is a previous patent that is related to the asserted patents. (Toth…opinion that the patent examiner, in allowing the ʼ727 patent and the asserted patents to issue, relied…of the ’715 patent, claim 8 of the ’677 patent, claim 8 of the ’652 patent, and claim 6…of the ’335 patent, claim 17 of the ’652 patent, claim 5 of the ’929 patent, and claim External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.